EE97 Budget Impact Analysis of Subcutaneous Ocrelizumab for Relapsing Multiple Sclerosis in Italy: A Hospital Perspective
Abstract
Authors
Paolo Di Procolo Giuseppina Marrazzo Camilla Porta Lorenzo Pradelli Raffaele Palladino Vincenzo Brescia Morra Marcello Moccia